BIM
SLXP

BlackRock Investment Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock Investment Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-179,891
Closed -$31.1M – 4316
2015
Q1 		$31.1M Sell
179,891
-9,399
-5% -$1.38M 0.04% 403
2014
Q4 		$21.8M Buy
189,290
+5,704
+3% +$691K 0.03% 512
2014
Q3 		$28.7M Sell
183,586
-78,124
-30% -$11.3M 0.04% 404
2014
Q2 		$32.3M Buy
261,710
+88,023
+51% +$9.73M 0.04% 388
2014
Q1 		$18M Sell
173,687
-1,452
-0.8% -$149K 0.03% 567
2013
Q4 		$15.8M Buy
175,139
+1,298
+0.7% +$104K 0.02% 615
2013
Q3 		$11.6M Buy
173,841
+125,612
+260% +$8.66M 0.02% 740
2013
Q2 		$3.19M Buy
+48,229
New +$2.76M 0.01% 1521

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock Investment Management's SLXP Position: Q2 2015 in Review

BlackRock Investment Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 179,891 shares — an estimated $31.1M sold.

BlackRock Investment Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $32.3M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BlackRock Investment Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 179,891 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $31.1M.
  • BlackRock Investment Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BlackRock Investment Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $32.3M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.